Proteasome: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
<StructureSection load='' size=' | <StructureSection load='' size='350' side='right' scene='41/417543/Cv/1' caption='Yeast proteasome 20S core complex with salinosporamide derivative, [[3gpt]]'> | ||
== Function == | == Function == | ||
Line 41: | Line 41: | ||
*Proteasome 20S+inhibitor | *Proteasome 20S+inhibitor | ||
**[[3hye]], [[3gpj]], [[3dy3]], [[3dy4]], [[3e47]], [[3d29]], [[3bdm]], [[2zcy]], [[2gpl]], [[2fak]], [[2f16]], [[1jd2]], [[1g65]], [[3mg0]], [[3mg4]], [[3mg6]], [[3mg7]], [[3mg8]], [[3oeu]], [[3oev]], [[3okj]], [[3shj]], [[3un4]], [[3un8]], [[3sdi]], [[3sdk]], [[4fzc]], [[4fzg]], [[4gk7]], [[4eu2]], [[4inr]], [[4int]], [[4inu]], [[4jsq]], [[4jsu]], [[4jt0]], [[4qwx]], [[4qzz]], [[4r17]], [[4r18]], [[4rur]], [[5ahj]], [[4y69]], [[4y6v]], [[4y6z]], [[4y70]], [[4y74]], [[4y75]], [[4y77]], [[4y78]], [[4y7w]], [[4y7x]], [[4y7y]], [[4y80]], [[4y81]], [[4y82]], [[4y8g]], [[4y8h]], [[4y8i]], [[4y8j]], [[4y8k]], [[4y8l]], [[4y8m]], [[5dki]], [[5dkj]], [[5l52]], [[5l54]], [[5l55]], [[4y6a]], [[4y84]], [[4y8n]], [[4y8o]], [[4y8p]], [[4y8q]], [[4y8s]], [[4y8t]], [[4y8u]], [[4y9z]], [[4ya0]], [[4ya2]], [[4ya3]], [[4ya5]], [[4ya7]], [[4ya9]] | **[[3hye]], [[3gpj]], [[3dy3]], [[3dy4]], [[3e47]], [[3d29]], [[3bdm]], [[2zcy]], [[2gpl]], [[2fak]], [[2f16]], [[1jd2]], [[1g65]], [[3mg0]], [[3mg4]], [[3mg6]], [[3mg7]], [[3mg8]], [[3oeu]], [[3oev]], [[3okj]], [[3shj]], [[3un4]], [[3un8]], [[3sdi]], [[3sdk]], [[4fzc]], [[4fzg]], [[4gk7]], [[4eu2]], [[4inr]], [[4int]], [[4inu]], [[4jsq]], [[4jsu]], [[4jt0]], [[4qwx]], [[4qzz]], [[4r17]], [[4r18]], [[4rur]], [[5ahj]], [[4y69]], [[4y6v]], [[4y6z]], [[4y70]], [[4y74]], [[4y75]], [[4y77]], [[4y78]], [[4y7w]], [[4y7x]], [[4y7y]], [[4y80]], [[4y81]], [[4y82]], [[4y8g]], [[4y8h]], [[4y8i]], [[4y8j]], [[4y8k]], [[4y8l]], [[4y8m]], [[5dki]], [[5dkj]], [[5l52]], [[5l54]], [[5l55]], [[4y6a]], [[4y84]], [[4y8n]], [[4y8o]], [[4y8p]], [[4y8q]], [[4y8s]], [[4y8t]], [[4y8u]], [[4y9z]], [[4ya0]], [[4ya2]], [[4ya3]], [[4ya5]], [[4ya7]], [[4ya9]], | ||
[[5jhr]], [[5jhs]], [[5lai]], [[4r02]], [[2zcy]], [[5bou]], [[5laj]] – y20S core+inhibitor<br /> | |||
**[[4qxj]], [[4qz0]], [[4qz1]], [[4qz2]], [[4qz3]], [[4qz4]], [[4qz5]], [[4qz6]], [[4qz7]], [[4qzw]], [[4qzx]], [[4r00]], [[4r02]], [[5cgg]], [[5cgh]], [[5cgi]], [[5d0t]], [[5fgh]] – y20S (mutant) + inhibitor<br /> | **[[4qxj]], [[4qz0]], [[4qz1]], [[4qz2]], [[4qz3]], [[4qz4]], [[4qz5]], [[4qz6]], [[4qz7]], [[4qzw]], [[4qzx]], [[4r00]], [[4r02]], [[5cgg]], [[5cgh]], [[5cgi]], [[5d0t]], [[5fgh]] – y20S (mutant) + inhibitor<br /> | ||
**[[4hnp]], [[4hrc]], [[4hrd]], [[4lqi]], [[4ltc]], [[4q1s]] - y20S core + antibiotics<br /> | **[[4hnp]], [[4hrc]], [[4hrd]], [[4lqi]], [[4ltc]], [[4q1s]] - y20S core + antibiotics<br /> |
Revision as of 13:02, 27 August 2018
FunctionProteasome (PRTS) are large protein complexes which degrade unneeded proteins into small polypeptides[1]. The 26S PRTS is composed of a central 20S core particle which contains 4 stacked rings each with several members and two 19S caps. The 19S cap is composed of a base with 10 proteins six of which are ATPases and a lid which contains 9 proteins which bind polyubiquitin. For more details see 3unb. Structural highlightsThe core particle two outer rings contain 7 α subunits (Y7, Y13, PRE6, PRE5, PUP2, C1, C7-α) which form the PRTS gate. The two inner rings contain 7 β subunits (PRE2, PRE4, PRE3, PUP1, PUP3, C5, C11) with protease activity[2].
|
|
3D Structures of Proteasome3D Structures of Proteasome
Updated on 27-August-2018
5jhr, 5jhs, 5lai, 4r02, 2zcy, 5bou, 5laj – y20S core+inhibitor
- 4qxj, 4qz0, 4qz1, 4qz2, 4qz3, 4qz4, 4qz5, 4qz6, 4qz7, 4qzw, 4qzx, 4r00, 4r02, 5cgg, 5cgh, 5cgi, 5d0t, 5fgh – y20S (mutant) + inhibitor
- 4hnp, 4hrc, 4hrd, 4lqi, 4ltc, 4q1s - y20S core + antibiotics
- 4nnn, 4nnw, 4no1, 4no6, 4no8, 4no9, 4qby, 4qlq, 4qls, 4qlt, 4qlu, 4qlv - y20S core+ peptide inhibitor
- 5cz6, 5cz7 - y20S (mutant) + peptide inhibitor
- 3h6f, 3h6i, 3hf9, 2fhh, 3krd – Mt20S core+inhibitor
- 3nzj, 3nzw, 3nzx - y20S + TMC-95A mimic ligand
- 4qvl, 4qw4, 4z1l, 3tdd, 4j70 – y20S + cancer drug
- 4qvm, 4qvn, 4qvp, 4qvq, 4qvv, 4qvw, 4qvy, 4qw0, 4qw1, 4qw3, 4qw5, 4qw6, 4qw7, 4qwf, 4qwg, 4qwi, 4qwj, 4qwk, 4qwl, 4qwr, 4qws, 4qwu, 5cz8, 5cz9, 5fgd, 5fge, 5fgf, 5fgg, 5fgi, 5fhs, 5d0z, 5d0x, 5d0v, 5d0s, 5cz5, 5bxn - y20S (mutant) + cancer drug
- 4r67 – h20S + cancer drug
- 4x6z - y20S + modulator
- 5gjq - y20S + ubiquitin carboxyl hydrolase 14 + polyubiquitin
- 5l5a - y20S + h20S beta5i
- 5ltt - y20S + h20S beta5i + inhibitor
- 5l5b, 5l5r - y20S + h20S beta5i + h20S beta6
- 5l5w - y20S + h20S beta5c + h20S beta6
- 5l5x, 5l60, 5l61 - y20S + h20S beta5c + h20S beta6 + inhibitor
- 5l5y, 5l5z - y20S + h20S beta5c + h20S beta6 + cancer drug
- 5l5d, 5l5h, 5l5q, 5l5i, 5l5j, 5l5o, 5l5p, 5l5s, 5l5t, 5l5u, 5l5v, 5l62, 5l63, 5l64, 5l68, 5l69, 5l6a, 5l6c, 5m2b - y20S + h20S beta5i + h20S beta6 + inhibitor
- 5l5e, 5l5f - y20S + h20S beta5i + h20S beta6 + cancer drug
- 5l65, 5l66 - y20S + m20S beta5i + m20S beta6 + cancer drug
- 5l67, 5l6b - y20S + m20S beta5i + m20S beta6 + inhibitor
- 3unb, 3unf – m20S + inhibitor
- 5ley, 5lf0, 5lf1, 5lf3, 5lf4, 5lf7, 5lez, 5lf6 - h20S + inhibitor
- 5a0q - h20S + substrate analog
- 5fmg - Pf20S + inhibitor - Plasmodium falciparum - Cryo EM
- 5trr, 5trs, 5try, 5ts0, 5tho, 5trg - Mt20S + peptide
- 4qxj, 4qz0, 4qz1, 4qz2, 4qz3, 4qz4, 4qz5, 4qz6, 4qz7, 4qzw, 4qzx, 4r00, 4r02, 5cgg, 5cgh, 5cgi, 5d0t, 5fgh – y20S (mutant) + inhibitor
- Proteasome partial 20S particle
- Proteasome partial 26S particle
- 5l4k - hPRTS lid - CryoEM
- 5dsv - hPRTS subunit a type-3
- 1p9c – hPRTS subunit 4 C-terminal
- 1p9d - hPRTS subunit 4 C-terminal + HHR23A ubiquitin-like domain
- 1uel - hPRTS subunit 4 C-terminal + HHR23A ubiquitin-like domain - NMR
- 1yx4 - hPRTS subunit 4 – NMR
- 1yx5, 1yx6, 2kde, 2kdf - hPRTS subunit 4+ubiquitin – NMR
- 2o95, 2o96 - hPRTS subunit 7
- 3kw6 - hPRTS subunit 8
- 2krk - hPRTS subunit 8 – NMR
- 1qym, 1uoh - hPRTS subunit 10
- 1tr4 - hPRTS subunit 10 – NMR
- 4nik - hPRTS subunit 10 + single-chain Fv
- 3t5x - hPRTS subunit Dss1 + PCI domain-containing protein 2
- 2dvw, 2dwz - mPRTS subunit 10 + hPRTS subunit 6B – mouse
- 3aji - mPRTS subunit 10 + subunit 4
- 2x5n - PRTS subunit RPN10 VWA domain – fission yeast
- 4ady - yPRTS subunit RPN2
- 3vlf - yPRTS subunit 7 + DNA mismatch repair protein
- 2mr3 - yPRTS subunit RPN9 – NMR
- 2mqw - yPRTS subunit RPN9 N terminal – NMR
- 2mri - yPRTS subunit RPN9 C terminal – NMR
- 4b0z - yPRTS subunit RPN12
- 2z4d - yPRTS subunit RPN13
- 3vl1 - yPRTS subunit RPN14 (mutant)
- 4o8x, 4o8y - yPRTS subunit RPN8 + RPN11
- 4ocl, 4ocm, 4ocn - yPRTS subunit RPN8 + RPN11 + nanobody
- 3t5v - yPRTS subunit SEM1 + nuclear mRNA export proteins SAC3 and THP1
- 2z59 - mPRTS subunit RPN13+ubiquitin
- 3txm, 3txn – PRTS subunit P42B – Drosophila melanogaster
- 5l4k - hPRTS lid - CryoEM
- Proteasome 26S particle
- 3j47, 4cr2, 4cr3, 4cr4, 5wvi, 5mpc – yPRTS – Cryo EM
- 5wvk - yPRTS + ADP - Cryo EM
- 5mp9, 5mpa, 5mpd, 5mpe - yPRTS + ATP - Cryo EM
- 5mpb - yPRTS + AMPPNP - Cryo EM
- 4g4s – yPRTS + proteasome assembly chaperon 1 & 2
- 5a5b - yPRTS + UBP6 - Cryo EM
- 5l4g, 5gjr, 5ln3, 5t0c, 5t0g, 5t0h, 5t0i, 5t0j - hPRTS - Cryo EM
- 5m32 - hPRTS + inhibitor - Cryo EM
- 3j47, 4cr2, 4cr3, 4cr4, 5wvi, 5mpc – yPRTS – Cryo EM
ReferencesReferences
- ↑ Saeki Y, Tanaka K. Assembly and function of the proteasome. Methods Mol Biol. 2012;832:315-37. doi: 10.1007/978-1-61779-474-2_22. PMID:22350895 doi:http://dx.doi.org/10.1007/978-1-61779-474-2_22
- ↑ Coux O, Tanaka K, Goldberg AL. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem. 1996;65:801-47. PMID:8811196 doi:http://dx.doi.org/10.1146/annurev.bi.65.070196.004101